OVERVIEW

Module 2 – Compartment-Based Management: Tailoring Therapy to Disease Burden is organized by i3 Health.

Dates Available:
August 27, 2026 - August 26, 2027

STATEMENT OF NEED:
Cutaneous T-cell lymphoma (CTCL), including mycosis fungoides and Sézary syndrome, requires multidimensional assessment because disease may manifest independently or concurrently in the skin, peripheral blood, lymph nodes, and visceral organs. TNMB staging and standardized response criteria provide a framework for measuring disease burden and evaluating treatment response across these compartments. Module 2 of this Clinical Insights Microlearning Series will explore objective assessment of each CTCL disease compartment, how compartment burden informs treatment selection, how to define clinically meaningful response, and how to manage discordant improvement or progression during therapy. It will feature insights from Larisa J. Geskin, MD, FAAD, Professor of Dermatology in Medicine at Columbia University Irving Medical Center, and Steven M. Horwitz, MD, Member and Attending Physician at Memorial Sloan Kettering Cancer Center.

Learning Objectives:
Upon completion of this activity, participants should be able to:

Apply compartment-based assessment in CTCL to determine how discordant responses impact treatment selection and monitoring strategies

ACCREDITATION & CREDITS

Ointly Accredited Provider:
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:
i3 Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME MOC badge graphic:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.

Physician Assistants/Associates:
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 8/26/27. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners:
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Nursing Continuing Professional Development:
A maximum of 0.5 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.5 contact hours of pharmacology credit for Advanced Practice Registered Nurses.

Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 0.5 ANCC contact hours.
Credit:
0.5 AMA PRA Category 1 Credit™
0.5 AAPA Category 1 CME credit
0.5 ANCC contact hour
0.5 ANCC contact hours of pharmacology content for APRNs
0.5 ACPE credit

0.5 AMA PRA Category 1 Credit™

0.5 Contact Hours

0.5 MOC

0.5 AAPA

0.5 CE Hours

TARGET AUDIENCE

PhysicianNursingPharmacistPhysician AssistantOncologistsDermatologistsNursesHematologistsNurse PractitionersAdvanced Practice ProvidersOncology Nurses